Not sure where you get your timeframe from - a number of factors, trials and work to date including BV suggest "fast track" will be what the term suggests.
Excerpt from a recent interview:
DR JACKIE FAIRLEY, CEO OF STARPHARMA : "VivaGel taking consideration of the various elements, such as funding and regulatory requirements to satisfy for a product such as this, we expect that the product would be available in its various forms probably within the next two to three years."
But I must admit Im out of my depth with regard to the technicalities of this!
vectorvest values starpharma at under 20 cents, page-3
-
- There are more pages in this discussion • 9 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add SPL (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
10.0¢ |
Change
0.001(1.01%) |
Mkt cap ! $42.85M | |||
| Open | High | Low | Value | Volume |
| 9.9¢ | 10.3¢ | 9.9¢ | $144.0K | 1.434M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 3 | 1289178 | 10.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 10.5¢ | 246283 | 7 |
View Market Depth
| Last trade - 14.27pm 08/11/2024 (20 minute delay) ? |
| SPL (ASX) Chart |